Sensei Biotherapeutics, Inc. (SNSE)
USD 0.43
(-11.1%)
USD 0.43
(-11.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -32.02 Million | -39.02 Million | -30.25 Million | -17.7 Million | -8.57 Million | -10.31 Million |
| Net Income | -34.1 Million | -48.58 Million | -36.79 Million | -20.1 Million | -16.74 Million | -13.03 Million |
| Depreciation & Amortization | 571 Thousand | 1.34 Million | 685 Thousand | 209 Thousand | 73 Thousand | 44 Thousand |
| Deferred income taxes | 2.33 Million | - | 19 Thousand | -1.04 Million | 1.97 Million | - |
| Stock-based compensation | 4.45 Million | 5.81 Million | 5.65 Million | 1.49 Million | 1.17 Million | 1.19 Million |
| Change in working capital | -4.33 Million | 1 Million | 117 Thousand | -397 Thousand | 3.46 Million | 1.49 Million |
| Other non-cash items | -948 Thousand | 1.39 Million | 57 Thousand | 2.13 Million | 1.47 Million | 349 Thousand |
| Investing Cash Flow | 38.41 Million | 49.94 Million | -143.11 Million | -1.4 Million | -53 Thousand | -31 Thousand |
| Investments in PPE | -180 Thousand | -321 Thousand | -2.02 Million | -1.2 Million | -53 Thousand | -31 Thousand |
| Acquisitions | 166 Thousand | 15 Thousand | 318 Thousand | -197 Thousand | - | - |
| Investment purchases | -21.14 Million | -46.86 Million | -183.66 Million | - | - | - |
| Sales/Maturities of investments | 59.57 Million | 97.12 Million | 42.25 Million | - | - | - |
| Other Investing Activities | 38.59 Thousand | 50.27 Thousand | -141.09 Thousand | -197 Thousand | - | - |
| Financing Cash Flow | -11.17 Million | -287 Thousand | 163.94 Thousand | 35.45 Million | 8.22 Million | 750 Thousand |
| Debt repayment | -761 Thousand | -629 Thousand | -255.00 | -41 Thousand | -27 Thousand | -750 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -10.38 Million | - | - | - | - | - |
| Common Stock Issuance | 48 Thousand | 238 Thousand | 164.11 Million | 541 Thousand | 154 Thousand | - |
| Other Financing Activities | -76 Thousand | 104 Thousand | 164.19 Thousand | 34.95 Million | 8.09 Million | 750 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.33 Million | 2.01 Million | -1.42 Million | 335 Thousand | 2.34 Million | 931 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.99 Million | -1 Million | 1.54 Million | -732 Thousand | 1.12 Million | 559 Thousand |
| Cash at beginning of period | 17.79 Million | 7.15 Million | 16.59 Million | 251 Thousand | 653 Thousand | 10.24 Million |
| Cash at end of period | 13.01 Million | 17.79 Million | 7.15 Million | 16.59 Million | 251 Thousand | 653 Thousand |
| Capital Expenditure | -180 Thousand | -321 Thousand | -2.02 Million | -1.2 Million | -53 Thousand | -31 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -4.78 Million | 10.63 Million | -9.43 Million | 16.34 Million | -402 Thousand | -9.59 Million |
| Free Cash Flow | -32.2 Million | -39.34 Million | -32.28 Million | -18.91 Million | -8.62 Million | -10.34 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.14 Million | -7.99 Million | -34.1 Million | -7.41 Million | -7.12 Million | -9.38 Million |
| Depreciation & Amortization | 135 Thousand | 137 Thousand | 571 Thousand | 135 Thousand | 332 Thousand | 332 Thousand |
| Deferred income taxes | - | - | 2.33 Million | 356 Thousand | -214 Thousand | -142 Thousand |
| Stock-based compensation | 795 Thousand | 1.21 Million | 4.45 Million | 1.09 Million | 1.04 Million | 1.09 Million |
| Change in working capital | 85 Thousand | -1.42 Million | -4.33 Million | -400 Thousand | 979 Thousand | -1.71 Million |
| Other non-cash items | 1.75 Million | 1.63 Million | -948 Thousand | 62 Thousand | 318 Thousand | 353 Thousand |
| Investing Cash Flow | 6.9 Million | 5.77 Million | 38.41 Million | 8.26 Million | 8.31 Million | 19.52 Million |
| Investments in PPE | -109 Thousand | -37 Thousand | -180 Thousand | - | - | -29 Thousand |
| Acquisitions | - | - | 166 Thousand | -166 Thousand | - | 157 Thousand |
| Investment purchases | -11.73 Million | -6.25 Million | -21.14 Million | -2.61 Million | -8.68 Million | -2000.00 |
| Sales/Maturities of investments | 18.75 Million | 12.06 Million | 59.57 Million | 10.87 Million | 17 Million | 19.4 Million |
| Other Investing Activities | 7016.00 | 5807.00 | 38.59 Thousand | 166 Thousand | 8312.00 | 19.55 Thousand |
| Financing Cash Flow | -180 Thousand | -209 Thousand | -11.17 Million | -431 Thousand | -2.53 Million | -7.94 Million |
| Debt repayment | -201 Thousand | -199 Thousand | -761 Thousand | -196 Thousand | -190 Thousand | -189 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -10.00 | -10.38 Million | -252 Thousand | -2.34 Million | -7.78 Million |
| Common Stock Issuance | - | - | 48 Thousand | 48 Thousand | - | - |
| Other Financing Activities | 21 Thousand | -10 Thousand | -76 Thousand | -31 Thousand | -10.13 Thousand | 31 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -354 Thousand | 306 Thousand | -2.33 Million | -781 Thousand | 471 Thousand | -2.26 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 439 Thousand | -1.73 Million | -1.99 Million | 381 Thousand | 508 Thousand | 548 Thousand |
| Cash at beginning of period | 10.95 Million | 13.01 Million | 17.79 Million | 11.34 Million | 10.22 Million | 8.1 Million |
| Cash at end of period | 11.89 Million | 10.95 Million | 13.01 Million | 13.01 Million | 11.34 Million | 10.22 Million |
| Capital Expenditure | -109 Thousand | -37 Thousand | -180 Thousand | - | - | -29 Thousand |
| Effect of forex changes on cash | - | - | - | 11.5 Million | - | -11.5 Million |
| Net cash flow / Change in cash | 935 Thousand | -2.05 Million | -4.78 Million | 1.66 Million | 1.11 Million | 2.11 Million |
| Free Cash Flow | -5.9 Million | -7.65 Million | -32.2 Million | -6.16 Million | -4.66 Million | -9.49 Million |
CVNA
WORL
COFORGE
TGII
SMARTLINK
MBINO